Baker Bros. Advisors LP 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-28 5:29 pm Purchase |
2020-07-21 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA |
Baker Bros. Advisors LP | 2,903,030 9.200% |
6,253 (+0.22%) |
Filing |
| 2020-05-18 5:21 pm Purchase |
2020-05-13 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA |
Baker Bros. Advisors LP | 2,896,777 11.500% |
31,268 (+1.09%) |
Filing |